Treatment of early Parkinson's disease: Part 1

Tanya Simuni*, Kelly E. Lyons, Rajesh Pahwa, Robert A. Hauser, Cynthia Comella, Lawrence Elmer, Daniel Weintraub

*Corresponding author for this work

Research output: Contribution to journalReview article

10 Scopus citations

Abstract

The management of early Parkinson's disease (PD) involves the treatment of motor symptoms and, increasingly, non-motor symptoms. Given the fast pace of clinical research in PD, clinicians are faced with the challenge of integrating the latest findings into the ongoing care of individual PD patients. Part 1 of this 2-part article reviews motor symptom efficacy data for the newest PD treatment options, as well as for established therapies. Safety and tolerability data are also reviewed. Part 2 of the article reviews key findings relevant to the assessment of potential neuroprotective therapies and the treatment of non-motor symptoms.

Original languageEnglish (US)
Pages (from-to)193-205
Number of pages13
JournalEuropean Neurology
Volume61
Issue number4
DOIs
StatePublished - Mar 1 2009

Keywords

  • Dopamine agonists
  • Levodopa
  • Monoamine oxidase B inhibitors
  • Parkinson's disease

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Treatment of early Parkinson's disease: Part 1'. Together they form a unique fingerprint.

  • Cite this

    Simuni, T., Lyons, K. E., Pahwa, R., Hauser, R. A., Comella, C., Elmer, L., & Weintraub, D. (2009). Treatment of early Parkinson's disease: Part 1. European Neurology, 61(4), 193-205. https://doi.org/10.1159/000197103